发明名称 1-Phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines useful as dopamine receptor ligands
摘要 A piperazine derivative or pharmaceutically acceptable addition salts thereof has the formula (I) wherein: R1, R2, R3 and R4 are independently hydrogen, halogen, alkyl, alkoxy, alkylthio, hydroxy, amino, mono or di alkylamino, cyano, nitro, perfluoroalkyl or perfluoroalkoxy and R5, R6, R7, and R8 are independently hydrogen or alkyl; provided that neither R1 or R2 is t-butyl and at least one of R3 and R4 are halogen. The compounds are useful for treating schizophrenia, mania, dementia, depression, anxiety, obsessive-compulsive disorder, substance abuse, Parkinson-like motor disorder or a motion disorder related to the use of a neuroleptic agent.
申请公布号 NZ512772(A) 申请公布日期 2003.11.28
申请号 NZ20000512772 申请日期 2000.01.06
申请人 NEUROGEN CORPORATION 发明人 TRAN, JENNIFER;ZHAO, HE;THURKAUF, ANDREW;ZHANG,XIAOYAN
分类号 C07D295/02;A61K31/495;A61P25/00;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;C07D295/03;C07D295/04;C07D295/06;C07D295/073;C07D295/135;(IPC1-7):C07D295/06;C07D295/12 主分类号 C07D295/02
代理机构 代理人
主权项
地址